Georgiamune
Gaithersburg, Maryland, United States · Biotechnology, Health Care, Medical
Georgiamune Inc. is a clinical-stage science and discovery biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Georgiamune has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. The company's lead program, GIM-122, is a firs
Key facts
- Headquarters
- Gaithersburg, Maryland, United States
- Employees
- 29
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- www.georgiamune.com
- Company page
Recent activity at Georgiamune
Georgiamune funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2026 | Venture | $92.7M |
Leadership
- Mark Avagliano, Chief Business Officer
Verified email and direct lines for Georgiamune’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Georgiamune files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Georgiamune in the news
- Menarini's Stemline picks up Georgiamune preclinical cancer immunotherapy in $1.1B deal - Fierce Biotech (Oct 22, 2026)
- Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent - Business Wire (Oct 22, 2026)
- Georgiamune Inc. Achieves US FDA Clearance for Investigational New Drug (IND) Application and Secures $75 Million in Series A Financing - PR Newswire (Aug 09, 2023)
Companies similar to Georgiamune
- Ellipses Pharma Limited · Biotechnology, Health Care, Medical, Therapeutics
- n-Lorem Foundation · Biotechnology, Health Care, Medical, Therapeutics
- Aethlon Medical · Biotechnology, Health Care, Medical, Therapeutics
- Ascidian Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- Imugene · Biotechnology, Health Care, Medical, Therapeutics
About Georgiamune: questions and answers
What does Georgiamune do?
Georgiamune Inc. is a clinical-stage science and discovery biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Georgiamune has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. The company's lead program, GIM-122, is a firs
Where is Georgiamune headquartered?
Georgiamune is headquartered in Gaithersburg, Maryland, United States.
How many employees does Georgiamune have?
Georgiamune has about 29 employees.
Has Georgiamune raised funding?
Yes. Fundz has recorded 1 funding event for Georgiamune. The most recent, $92.7M, was in Aug 2026.
What is the latest news on Georgiamune?
On Aug 17, 2026, Georgiamune
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy